PYPD

PolyPid's (PYPD) CEO Amir Weisberg on Q1 2021 Results - Earnings Call Transcript

PolyPid Ltd. Reports First Quarter 2021 Financial Results and Provides Corporate Update

PolyPid to Participate in Upcoming Investor Conferences

PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections

PolyPid's (PYPD) Management on Q4 2020 Results - Earnings Call Transcript

PolyPid to Report Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights on February 10, 2021

PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program